Thank you for downloading Oncodetect MRD White Paper

Oncodetect White Paper

Our white paper, “The Oncodetect™ MRD Test: Uncovering the Hidden Traces of Cancer and Empowering More Informed Cancer Decisions,” will help you learn more about how the Oncodetect MRD test works.

Two folders that say "Oncodetect MRD test: Uncovering the Hidden Traces of Cancer and Empowering Informed Cancer Decisions" sitting on an orange background.

Call us at 1-866-662-6897 or email at oncodetect@exactsciences.com.

Footnotes

This test was developed, and its performance characteristics determined by Genomic Health, Inc. The Oncodetect test was clinically validated in colorectal cancer patients with stage II-IV disease. Performance characteristics may not apply in tumor types not included in this test’s clinical validation. The test has not been cleared or approved by the US Food and Drug Administration. The test has been validated as a Laboratory Developed Test per institutional and applicable CLIA regulation (CLIA# 03D2048606) and College of American Pathology (CAP# 8869063) as qualified to perform high complexity clinical laboratory testing.

Thank you for requesting our recent white paper!

Have questions?

Footnotes